Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Frost & Sullivan Lauds Helicos BioSciences True Single-Molecule Sequencing™ Platform - Based on its recent analysis of the genome/transcriptome sequencing market, Frost & Sullivan presents Helicos BioSciences Corp. (NASDAQ: HLCS) with the 2008 North American Frost & Sullivan Award for Technology Innovation of the Year
Frost & Sullivan Lauds Helicos BioSciences True Single-Molecule Sequencing™ Platform

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2008/08/06 - Based on its recent analysis of the genome/transcriptome sequencing market, Frost & Sullivan presents Helicos BioSciences Corp. (NASDAQ: HLCS) with the 2008 North American Frost & Sullivan Award for Technology Innovation of the Year.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This Award is in recognition of Helicos' introduction of an advanced single-molecule sequencing platform that allows an entire genome to be cost-effectively sequenced in a very short amount of time.

Standard methods for sequencing genes require that the DNA be amplified many times – a time-consuming and expensive process. The first human genome was completed in 2003 after 3 years and a cost of 2.5 Billion Dollars. Last year, the first individual human genome was sequenced just a year ago for a cost of about $1 million.

The Helicos™ Genetic Analysis System enables extremely high-throughput genetic analysis by directly sequencing individual molecules of DNA. This allows an entire genome to be sequenced in about two weeks, for a cost of about $36,000. The cost will continue to drop as chemistries are further improved. A major advantage of the Helicos system is that these improvements will not require the purchase of expensive new equipment. Instead, only new reagents will be needed.

"Single-molecule DNA sequencing has been a goal of the scientific community for over 40 years," says Frost & Sullivan Research Analyst Dr. Kathryn Austin. "Helicos' proprietary True Single Molecule Sequencing (tSMS)™ technology, enables the simultaneous sequencing of large numbers of strands of single DNA or RNA molecules."

The tSMS™ technology – developed from the work of Dr. Stephen Quake at Stanford University – uses a proprietary form of "sequencing-by-synthesis", in which labeled DNA bases are sequentially added to the nucleic acid templates captured on a "flow cell". Each base addition is detected by the HeliScope™ Single Molecule Sequencer, which is at the heart of the system. This way the entire sequence of bound strands can be elucidated.

The advantages of tSMS compared to other DNA sequencing methods are undeniable. It enables the direct analysis of individual DNA molecules, without requiring a large number of copies of those molecules. The system does not require elaborate sample processing or amplification techniques, dramatically lowering the cost of individual genomic and genetic analyses. The simple sample preparation process can easily be scaled and replicated to meet the requirements of large, complex experiments, overcoming the workflow bottlenecks encountered by methods such as PCR or cloning.

"As an enabling technology for genomics research, Helicos' technology platform will allow researchers to accelerate their understanding of important but extremely complex diseases such as cancer and heart disease," notes Austin. "The Helicos Genetic Analysis System will have extensive applications in basic and pharmaceutical R&D, from diagnostics to prognostic indicators to more effective therapies, increasing the potential for personalized medicine and more accurate molecular diagnostics. One especially promising capability is rapid sequencing of the "transcriptome", allowing quantitative analysis of gene expression through mRNA levels."

The company is planning future generations of chemistry that will ultimately allow customers to access the full power of the HeliScope Sequencer and enable human genome analysis at or below $1,000.

For these achievements, Frost & Sullivan is pleased to present Helicos BioSciences Corp. with the 2008 Award for Technology Innovation of the Year.

Each year, Frost & Sullivan presents this Award to the company that has carried out new research, which has resulted in innovation(s) that have or are expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. The Award recognizes the quality and depth of a company's research and development program as well as the vision and risk-taking that enabled it to undertake such an endeavor.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Helicos BioSciences Corp.

Helicos BioSciences (helicosbio.com) is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing, tSMS™, technology allows direct measurement of billions of strands of DNA enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617)264-1800.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Lauds Helicos BioSciences True Single-Molecule Sequencing™ Platform

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Jake Wengroff 
210.247.3806 jake.wengroff[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today